ReviewMedical oncology (Northwood, London, England)2022

CDK9 inhibitors in multiple myeloma: a review of progress and perspectives.

Jędrzej Borowczak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.